Toyoshima Osamu, Nishizawa Toshihiro, Sekiba Kazuma, Matsuno Tatsuya, Kondo Ryo, Watanabe Hidenobu, Suzuki Hidekazu, Tanikawa Chizu, Koike Kazuhiko, Matsuda Koichi
Gastroenterology, Toyoshima Endoscopy Clinic, 6-17-5 Seijo, Setagaya, Tokyo 157-0066, Japan.
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan.
J Clin Biochem Nutr. 2021 Jan;68(1):73-77. doi: 10.3164/jcbn.20-67. Epub 2020 Jul 31.
The risk allele of a single nucleotide polymorphism (SNP) rs2294008 in the () gene is strongly associated with gastric cancer. Although the Kyoto classification score is believed to be an indicator of gastric cancer risk, it lacks supporting genetic evidence. We investigated the effect of this risk allele of SNP on the Kyoto score. Participants without a history of gastric cancer or () eradication underwent esophagogastroduodenoscopy, evaluation, and SNP genotyping. The Kyoto score is the sum of scores obtained from endoscopy-based atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness. The Kyoto score is novel in the light of scoring for gastritis. A total of 323 patients were enrolled (number of individuals with genotype CC: 52; CT: 140; TT: 131, average age: 50.1 years, male: 50.8%). The patient baseline characteristics including age, sex, body mass index, smoking, drinking, family history of gastric cancer, and status had no association with SNP. The Kyoto score was higher in T (CT or TT genotype; risk allele) carriers than in CC carriers. Atrophy, enlarged folds, and diffuse redness scores were higher in T allele carriers (risk allele) than in CC genotype individuals. In multivariate analysis, the Kyoto score was independently associated with SNP (OR: 1.30, = 0.012). Thus, the Kyoto score was associated with a genetic predisposition.
()基因中一个单核苷酸多态性(SNP)rs2294008的风险等位基因与胃癌密切相关。尽管京都分类评分被认为是胃癌风险的一个指标,但它缺乏遗传学证据支持。我们研究了该SNP风险等位基因对京都评分的影响。没有胃癌病史或()根除史的参与者接受了食管胃十二指肠镜检查、评估和SNP基因分型。京都评分是基于内镜检查的萎缩、肠化生、皱襞增大、结节和弥漫性发红所获评分的总和。就胃炎评分而言,京都评分是新颖的。共纳入323例患者(基因型CC者52例;CT者140例;TT者131例,平均年龄:50.1岁,男性:50.8%)。患者的基线特征,包括年龄、性别、体重指数、吸烟、饮酒、胃癌家族史和()状态,与SNP均无关联。T(CT或TT基因型;风险等位基因)携带者的京都评分高于CC携带者。T等位基因携带者(风险等位基因)的萎缩、皱襞增大和弥漫性发红评分高于CC基因型个体。在多变量分析中,京都评分与SNP独立相关(比值比:1.30, = 0.012)。因此,京都评分与遗传易感性相关。